Literature DB >> 26051282

Study of the anti-inflammatory effects of low-dose radiation: The contribution of biphasic regulation of the antioxidative system in endothelial cells.

Martin Large1, Stephanie Hehlgans, Sebastian Reichert, Udo S Gaipl, Claudia Fournier, Claus Rödel, Christian Weiss, Franz Rödel.   

Abstract

BACKGROUND: We examined (a) the expression of the antioxidative factor glutathione peroxidase (GPx) and the transcription factor nuclear factor E2-related factor 2 (Nrf2) following low-dose X-irradiation in endothelial cells (ECs) and (b) the impact of reactive oxygen species (ROS) and Nrf2 on functional properties of ECs to gain further knowledge about the anti-inflammatory mode of action of low doses of ionizing radiation.
MATERIAL AND METHODS: EA.hy926 ECs and primary human dermal microvascular ECs (HMVEC) were stimulated by tumor necrosis factor-α (TNF-α, 20 ng/ml) 4 h before irradiation with single doses ranging from 0.3 to 3 Gy. The expression and activity of GPx and Nrf2 were analyzed by flow cytometry, colorimetric assays, and real-time PCR. The impact of ROS and Nrf2 on peripheral blood mononuclear cell (PBMC) adhesion was assayed in the presence of the ROS scavenger N-acetyl-L-cysteine (NAC) and Nrf2 activator AI-1.
RESULTS: Following a low-dose exposure, we observed in EA.hy926 EC and HMVECs a discontinuous expression and enzymatic activity of GPx concomitant with a lowered expression and DNA binding activity of Nrf2 that was most pronounced at a dose of 0.5 Gy. Scavenging of ROS by NAC and activation of Nrf2 by AI-1 significantly diminished a lowered adhesion of PBMC to EC at a dose of 0.5 Gy.
CONCLUSION: Low-dose irradiation resulted in a nonlinear expression and activity of major compounds of the antioxidative system that might contribute to anti-inflammatory effects in stimulated ECs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26051282     DOI: 10.1007/s00066-015-0848-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  42 in total

1.  Mononuclear cell adhesion and cell adhesion molecule liberation after X-irradiation of activated endothelial cells in vitro.

Authors:  G Hildebrandt; L Maggiorella; F Rödel; V Rödel; D Willis; K-R Trott
Journal:  Int J Radiat Biol       Date:  2002-04       Impact factor: 2.694

Review 2.  Redox activation of Nrf2 & NF-κB: a double end sword?

Authors:  Mabel Buelna-Chontal; Cecilia Zazueta
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

Review 3.  How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues.

Authors:  M H Barcellos-Hoff
Journal:  Radiat Res       Date:  1998-11       Impact factor: 2.841

4.  Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene.

Authors:  J Jeyapaul; A K Jaiswal
Journal:  Biochem Pharmacol       Date:  2000-06-01       Impact factor: 5.858

Review 5.  Reactive oxygen species in the immune system.

Authors:  Yuhui Yang; Alexandr V Bazhin; Jens Werner; Svetlana Karakhanova
Journal:  Int Rev Immunol       Date:  2013-04-25       Impact factor: 5.311

Review 6.  Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.

Authors:  Wenge Li; Tin Oo Khor; Changjiang Xu; Guoxiang Shen; Woo-Sik Jeong; Siwang Yu; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2008-07-23       Impact factor: 5.858

7.  Inhibitory effect of simvastatin on the TNF-alpha- and angiotensin II-induced monocyte adhesion to endothelial cells is mediated through the suppression of geranylgeranyl isoprenoid-dependent ROS generation.

Authors:  Su-Young Park; Jong-Suk Lee; Yu Jin Ko; Ah Ra Kim; Mi Kyoung Choi; Mi-Kyoung Kwak; Han Gon Choi; Chul Soon Yong; Jung-Ae Kim
Journal:  Arch Pharm Res       Date:  2008-02       Impact factor: 4.946

8.  Response of the Nrf2 protection system in human monocytic cells after ionising irradiation.

Authors:  H Yoshino; T Kiminarita; Y Matsushita; I Kashiwakura
Journal:  Radiat Prot Dosimetry       Date:  2012-08-31       Impact factor: 0.972

9.  The accumulation of un-repairable DNA damage in laminopathy progeria fibroblasts is caused by ROS generation and is prevented by treatment with N-acetyl cysteine.

Authors:  Shane A Richards; Joanne Muter; Pamela Ritchie; Giovanna Lattanzi; Christopher J Hutchison
Journal:  Hum Mol Genet       Date:  2011-08-01       Impact factor: 6.150

10.  Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion.

Authors:  Paola Chiarugi; Giovambattista Pani; Elisa Giannoni; Letizia Taddei; Renata Colavitti; Giovanni Raugei; Mark Symons; Silvia Borrello; Tommaso Galeotti; Giampietro Ramponi
Journal:  J Cell Biol       Date:  2003-06-09       Impact factor: 10.539

View more
  23 in total

1.  Radiotherapy of indolent orbital lymphomas : Two radiation concepts.

Authors:  Laila König; Robert Stade; Juliane Rieber; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2016-05-09       Impact factor: 3.621

2.  Flying by the seat of our pants: is low dose radiation therapy for COVID-19 an option?

Authors:  Dörthe Schaue; William H McBride
Journal:  Int J Radiat Biol       Date:  2020-05-26       Impact factor: 2.694

3.  Radiotherapy of painful heel spur with two fractionation regimens : Results of a randomized multicenter trial after 48 weeks' follow-up.

Authors:  Benjamin Prokein; Henrik Holtmann; Matthias G Hautmann; Hans-Peter Rösler; Stefan Graeber; Yvonne Dzierma; Christian Ruebe; Jochen Fleckenstein; Marcus Niewald
Journal:  Strahlenther Onkol       Date:  2017-02-27       Impact factor: 3.621

Review 4.  Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies.

Authors:  Michael Rückert; Lisa Deloch; Rainer Fietkau; Benjamin Frey; Markus Hecht; Udo S Gaipl
Journal:  Strahlenther Onkol       Date:  2018-03-02       Impact factor: 3.621

5.  Temporarily increased TGFβ following radon spa correlates with reduced pain while serum IL-18 is a general predictive marker for pain sensitivity.

Authors:  Miriam Kullmann; Paul F Rühle; Alexandra Harrer; Anna Donaubauer; Ina Becker; Renate Sieber; Gerhart Klein; Claudia Fournier; Rainer Fietkau; Udo S Gaipl; Benjamin Frey
Journal:  Radiat Environ Biophys       Date:  2018-11-19       Impact factor: 1.925

6.  Electrosmog and autoimmune disease.

Authors:  Trevor G Marshall; Trudy J Rumann Heil
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Measuring Leukocyte Adhesion to (Primary) Endothelial Cells after Photon and Charged Particle Exposure with a Dedicated Laminar Flow Chamber.

Authors:  Nadine Erbeldinger; Felicitas Rapp; Svetlana Ktitareva; Philipp Wendel; Anna S Bothe; Till Dettmering; Marco Durante; Thomas Friedrich; Bianca Bertulat; Stephanie Meyer; M C Cardoso; Stephanie Hehlgans; Franz Rödel; Claudia Fournier
Journal:  Front Immunol       Date:  2017-06-01       Impact factor: 7.561

8.  Distinct biological effects of low-dose radiation on normal and cancerous human lung cells are mediated by ATM signaling.

Authors:  Guozi Yang; Dehai Yu; Wei Li; Yuguang Zhao; Xue Wen; Xinyue Liang; Xiaoying Zhang; Lei Zhou; Jifan Hu; Chao Niu; Huimin Tian; Fujun Han; Xiao Chen; Lihua Dong; Lu Cai; Jiuwei Cui
Journal:  Oncotarget       Date:  2016-11-01

Review 9.  Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications.

Authors:  Anja Derer; Lisa Deloch; Yvonne Rubner; Rainer Fietkau; Benjamin Frey; Udo S Gaipl
Journal:  Front Immunol       Date:  2015-10-08       Impact factor: 7.561

Review 10.  Transcription Factors in the Cellular Response to Charged Particle Exposure.

Authors:  Christine E Hellweg; Luis F Spitta; Bernd Henschenmacher; Sebastian Diegeler; Christa Baumstark-Khan
Journal:  Front Oncol       Date:  2016-03-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.